TearLab (OTCMKTS:TEAR) Issues Earnings Results

TearLab (OTCMKTS:TEAR) (TSE:TLB) released its earnings results on Thursday. The medical research company reported ($0.10) earnings per share for the quarter, Bloomberg Earnings reports. The business had revenue of $5.85 million during the quarter.

TEAR traded down $0.01 during trading on Friday, reaching $0.07. The stock had a trading volume of 4,960 shares, compared to its average volume of 36,625. TearLab has a 1-year low of $0.03 and a 1-year high of $0.24. The stock has a 50 day simple moving average of $0.07.

About TearLab

TearLab Corporation operates as an in-vitro diagnostic company in the United States and internationally. It offers TearLab Osmolority System, a proprietary in vitro diagnostic tear testing platform that measures tear film osmolarity for the diagnosis of dry eye disease; and enables eye care practitioners to test for sensitive and specific biomarkers using nanoliters of tear film at the point-of-care.

Further Reading: Are sell-side analysts objective?

Earnings History for TearLab (OTCMKTS:TEAR)

Receive News & Ratings for TearLab Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for TearLab and related companies with MarketBeat.com's FREE daily email newsletter.